$RGBP SAN DIEGO, September 20, 2016 /PRNewswire/ -- Regen BioPharma Inc. (RGBP), (RGBPP) today announced completion of experiments demonstrating immunological effects of its novel NR2F6 small molecule modulators. These experiments were conducted in collaboration with Dr. Xiaojing Ma, Professor of Microbiology and Immunology at Weill Cornell Medical College. http://finance.yahoo.com/news/regen-biopharma...00084.html $WRAP $FDBL $CGRA $ACTL $RGEN